NCT02330926 2025-08-29
MENAC
Norwegian University of Science and Technology
Phase 3 Completed
Clinical Trials
11 trialsNCT03743051 2024-06-26
A Study to Evaluate the Efficacy and Safety of Anamorelin HCl for the Treatment of Malignancy Associated Weight Loss and Anorexia in Adult Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
Helsinn Healthcare SA
Phase 3 Completed
NCT03743064 2024-06-26
A Study to Evaluate the Efficacy and Safety of Anamorelin HCl for the Treatment of Malignancy Associated Weight Loss and Anorexia in Adult Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
Helsinn Healthcare SA
Phase 3 Completed
NCT00031785 2021-09-09
Megestrol in Treating Patients Who Are Undergoing Radiation Therapy for Lung Cancer
Wake Forest University Health Sciences
Phase 3 Completed
NCT00081250 2020-04-29
Creatine in Treating Patients With Cancer-Associated Weight Loss
Alliance for Clinical Trials in Oncology
Phase 3 Completed
NCT01387269 2017-10-27
Safety and Efficacy of Anamorelin HCl in Patients With Non-Small Cell Lung Cancer-Cachexia (ROMANA 1)
Helsinn Therapeutics (U.S.), Inc
Phase 3 Completed
NCT01387282 2017-10-27
Safety and Efficacy of Anamorelin HCl in Patients With Non-Small Cell Lung Cancer-Cachexia (ROMANA 2)
Helsinn Therapeutics (U.S.), Inc
Phase 3 Completed
NCT00053053 2016-12-08
Comparison of Nutritional Supplements in Preventing Weight Loss in Patients With Cancer
Radiation Therapy Oncology Group
Phase 3 Completed
NCT00040885 2016-12-07
Docetaxel With or Without Infliximab in Treating Weight Loss, Loss of Appetite, and Fatigue in Patients With Unresectable Non-Small Cell Lung Cancer (Infliximab Treatment Discontinued Effective 10/05/05)
Alliance for Clinical Trials in Oncology
Phase 3 Completed
NCT00513357 2012-12-11
Melatonin Versus Placebo and the Effect on Appetite in Advanced Cancer Patients
M.D. Anderson Cancer Center
Phase 3 Completed
NCT00046904 2011-05-05
Etanercept in Treating Cancer-Related Cachexia and Anorexia in Patients With Advanced Cancer
Mayo Clinic
Phase 3 Completed